fludeoxyglucose f18

Generic: fludeoxyglucose f18

Labeler: ucsf radiopharmaceutical facility
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fludeoxyglucose f18
Generic Name fludeoxyglucose f18
Labeler ucsf radiopharmaceutical facility
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

fludeoxyglucose f-18 300 mCi/mL

Manufacturer
UCSF Radiopharmaceutical Facility

Identifiers & Regulatory

Product NDC 24275-0185
Product ID 24275-0185_4395a8f3-f48b-e90c-e063-6294a90a7ae5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203902
Listing Expiration 2026-12-31
Marketing Start 2011-12-04

Pharmacologic Class

Established (EPC)
radioactive diagnostic agent [epc]
Mechanism of Action
radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 242750185
Hyphenated Format 24275-0185

Supplemental Identifiers

UNII
0Z5B2CJX4D
NUI
N0000177914 N0000000205

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f18 (source: ndc)
Generic Name fludeoxyglucose f18 (source: ndc)
Application Number ANDA203902 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 300 mCi/mL
source: ndc
Packaging
  • 17 mL in 1 VIAL, GLASS (24275-0185-1)
source: ndc

Packages (1)

24275-0185-1 17 mL in 1 VIAL, GLASS (24275-0185-1)

Ingredients (1)

fludeoxyglucose f-18 (300 mCi/mL)

Linked Drug Pages (1)

Fludeoxyglucose F18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "4395a8f3-f48b-e90c-e063-6294a90a7ae5", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["763958a2-6952-4c0d-8a4a-9c04acb62229"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["UCSF Radiopharmaceutical Facility"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "17 mL in 1 VIAL, GLASS (24275-0185-1)", "package_ndc": "24275-0185-1", "marketing_start_date": "20130102"}], "brand_name": "Fludeoxyglucose F18", "product_id": "24275-0185_4395a8f3-f48b-e90c-e063-6294a90a7ae5", "dosage_form": "INJECTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "24275-0185", "generic_name": "Fludeoxyglucose F18", "labeler_name": "UCSF Radiopharmaceutical Facility", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": "300 mCi/mL"}], "application_number": "ANDA203902", "marketing_category": "ANDA", "marketing_start_date": "20111204", "listing_expiration_date": "20261231"}